Article:Owen, J orcid.org/0000-0003-0778-0858, Kuznecovs, M, Bhamji, R et al. (7 more authors) (2020) High-throughput electrochemical sensing platform for screening nanomaterial-biomembrane interactions. Review of Scientific Instruments, 91 (2). 025002.
AbstractA high-throughput, automated screening platform has been developed for the assessment of biological membrane damage caused by nanomaterials. Membrane damage is detected using the technique of analysing capacitance-current peak changes obtained through rapid cyclic voltammetry (RCV) measurements of a phospholipid self-assembled monolayer, formed on a mercury film deposited onto a microfabricated platinum electrode, after the interaction of a biomembrane-active species. To significantly improve wider usability of the screening technique, a compact, high-throughput screening platform was designed, integrating the monolayer-supporting microfabricated electrode into a microfluidic flow cell, with bespoke pumps used for precise, automated control of fluid flow. Chlorpromazine, a tricyclic antidepressant, and citrate-coated 50 nm diameter gold nanomaterial (AuNM) were screened to successfully demonstrate the platform s viability for high-throughput screening. Chlorpromazine and AuNM showed interactions with a 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) monolayer at concentrations in excess of mol dm -3 . Biological validity of the electrochemically-measured interaction of chlorpromazine with DOPC monolayers was confirmed through quantitative comparisons with HepG2 and A549 cytotoxicity assays. The platform also demonstrated desirable performance for high-throughput screening, with membrane interactions detected in <6 min per assay. Automation contributed to this significantly, by reducing * Corresponding author: Joshua Owen (Email: J.J.Owen@leeds.ac.uk) the required operating skill level when using the technique and minimising fluid consumption.
KeywordsPhospholipid monolayer, gold nanomaterial, biomembrane interaction, microfluidic flow cell, mercury electrode, rapid cyclic voltammetry, high-throughput screening
IntroductionAdvances in nanotechnology have resulted in widespread usage of nanomaterials, often with applications in consumer products, biomedical and sensing technologies [1-4].However, toxicity hazards associated with nanomaterials have been widely reported, with growing research in the field of nanotoxicology emphasising the need for screening techniques to characterise nanomaterial hazards [5][6][7][8][9][10][11][12]. As the applications for engineered nanomaterials continues to grow, high-throughput, in vitro screening solutions are essential to accelerate the process of evaluating the toxicity of novel engineered nanomaterials and to meet the demand for hazard identification [13,14].High-throughput in vitro toxicity sensing technologies also provide an alternative to in vivo animal toxicity studies, which have ethical implications and are not economically feasible for screening a vast range of nanomaterials [3,15,16].Understanding cytotoxicity...